Katreena Davis of Georgia CORE discusses how the troubling rise of colon cancer in young people and Black people in ...

Prisma Health oncologist Dr. Ki Chung says since Brooks had stage four colorectal cancer, it had spread to her liver. The HAI ...

According to Cologuard, made by Wisconsin-based Exact Sciences, there are three primary reasons why you may receive a testing ...

Merck KGaA could now have a head start in the race to market Precem-TcT, which could become the first widely approved ADC in ...

Colorectal cancer is one of the most common tumors among people over the age of 50. Although it is known to develop from ...

A concerning sign of colon cancer, pencil-thin stools, is gaining attention. While often overlooked, this symptom can ...

From the stomach to the colon, researchers are uncovering how shifts in the gut microbiome may drive cancers across the ...

Colorectal cancer is a cancer that starts in the colon (large intestine) or rectum. Often, it begins as abnormal growths ...

BERLIN -- The investigational tyrosine kinase inhibitor (TKI) zanzalintinib plus atezolizumab (Tecentriq) significantly ...

Health is the fundamental engine in our lives. Science continues to take small steps to investigate the cure of the most ...

Their new findings on later-stage disease suggest that as well as reducing sugary drinks, targeting the SORD enzyme may offer opportunities to reduce colorectal cancer spread. Making revisions to ...

Alphamab Oncology (stock code: 9966.HK) announced that the biparatopic HER2-targeting antibody-drug conjugate (ADC) JSKN003, independently developed by the Company, and co-developed with JMT-Bio ...